← Leaderboards
Panupong Mahalapbutr
Khon Kaen University
$226,294
Attributed
$226,294
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $113.3K · FY2024–25$200K$150K$100K$50K$0
'24
'25
Funding mix
By agency
NIH$226,294 · 1
By mechanism
K43$226,294 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Affinity”
- Jason Dickens · Duke University$12,259,409
- Jeff T Hutchins · Inhalon Biopharma, Inc.$8,734,904
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- Michael P Weiner · Abbratech, Inc.$4,404,422
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$3,945,669
Research focus
AffinityAcquired Drug ResistanceAnti-CancerApplications GrantsAlpha HelixAspirateAwardBeta Pleated SheetBindingBiomaterial CompatibilityAqueousCaliforniaCancer CellCancer Cell LineCancer PatientCancer TherapyCancer TypeCareer DevelopmentCareer NetworkingCell SurfaceCharacteristicsChemical StabilityBypassChemotherapy
Grant awards (2)
Development of a smart transformable nanotherapeutic against cancers with acquired resistance to EGFR-targeted therapies caused by MET amplification$113,320
K43 · FY2025 · TW · contact PI
Development of a smart transformable nanotherapeutic against cancers with acquired resistance to EGFR-targeted therapies caused by MET amplification$112,974
K43 · FY2024 · TW · contact PI